Matrine inhibits the mRNA and protein expression of HIF-1α, thereby suppressing the transcription of GLUT1, HK2, and LDHA, the downstream targets of HIF-1, which are the key enzymes involved in the glycolytic energy metabolism of cancer cells. This evidence concerns the gene SLC2A1 and cancer.